Waimea

This research aims to find out if Pain Ease vapocoolant spray can reduce pain during lidocaine injection for patients receiving a Nexplanon implant. The study focuses on female patients aged 14 and older who are having the implant inserted in a specific clinic setting. The purpose is to compare the pain levels experienced during the lidocaine injection when using the vapocoolant spray versus a placebo spray. Participants will be randomly assigned to receive either the Pain Ease vapocoolant spray or a placebo spray made of normal saline before the lidocaine injection. The vapocoolant spray is applied for up to 5 seconds or until the skin turns white, according to manufacturer instructions. The placebo spray is applied to the arm similarly but contains no active cooling ingredients. During the procedure, pain levels will be measured immediately after the lidocaine injection. Eligible patients will be informed about the study and asked to provide written consent before participation. The study monitors pain relief effectiveness and safety for the duration of the implant insertion visit.